ResearcherUniversity Hospital HeidelbergActive in the last 2 years
Anna‐Katharina König
Matched on ORCID iD 0000-0001-6913-9367; OpenAlex author ID A5006016261, A5133048388. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 30
2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 3 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 7
- Impact of sarcopenia and myosteatosis on early and long-term survival after surgical resection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2026.04.007↗
- Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour grade. Co-author DOI 10.1016/j.ejso.2021.07.020↗
- Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds? Co-author DOI 10.1097/sla.0000000000004147↗
- A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000004845↗
- Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-derived organoids Co-author DOI 10.1101/2021.08.26.457743↗
- Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study. Co-author DOI 10.1002/ijc.31928↗
- Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation. Co-author DOI 10.1002/ijc.31047↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Markus Wolfgang Büchler · 5 shared papers, 2021–2026 · strength 0.78
- Paper Impact of sarcopenia and myosteatosis on early and long-term survival after surgical resection of pancreatic ductal ade… DOI 10.1016/j.pan.2026.04.007↗
- Paper Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour grade. DOI 10.1016/j.ejso.2021.07.020↗
- Paper A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer. DOI 10.1097/sla.0000000000004845↗
- Thomas P. Hank · 4 shared papers, 2022–2026 · strength 0.69
- Paper Impact of sarcopenia and myosteatosis on early and long-term survival after surgical resection of pancreatic ductal ade… DOI 10.1016/j.pan.2026.04.007↗
- Paper Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour grade. DOI 10.1016/j.ejso.2021.07.020↗
- Paper A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer. DOI 10.1097/sla.0000000000004845↗
- Oliver Strobel · 4 shared papers, 2021–2022 · strength 0.51
- Paper Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour grade. DOI 10.1016/j.ejso.2021.07.020↗
- Paper A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer. DOI 10.1097/sla.0000000000004845↗
- Paper Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds? DOI 10.1097/sla.0000000000004147↗
- Thilo Hackert · 3 shared papers, 2022 · strength 0.41
- Paper Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour grade. DOI 10.1016/j.ejso.2021.07.020↗
- Paper A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer. DOI 10.1097/sla.0000000000004845↗
- Paper Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds? DOI 10.1097/sla.0000000000004147↗
- Jörg Kaiser · 3 shared papers, 2022 · strength 0.41
- Paper Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour grade. DOI 10.1016/j.ejso.2021.07.020↗
- Paper A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer. DOI 10.1097/sla.0000000000004845↗
- Paper Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds? DOI 10.1097/sla.0000000000004147↗
- Mohammed Al‐Saeedi · 2 shared papers, 2022–2026 · strength 0.40
- Paper Impact of sarcopenia and myosteatosis on early and long-term survival after surgical resection of pancreatic ductal ade… DOI 10.1016/j.pan.2026.04.007↗
- Paper Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds? DOI 10.1097/sla.0000000000004147↗
- Miriam Klauß · 1 shared paper, 2026 · strength 0.28
- Ingmar Florin Rompen · 1 shared paper, 2026 · strength 0.28
- Martin Loos · 1 shared paper, 2026 · strength 0.28
- Philipp Mayer · 1 shared paper, 2026 · strength 0.28
- Niels Siegel · 1 shared paper, 2026 · strength 0.28
- Matthias M. Gaida · 2 shared papers, 2021–2022 · strength 0.22
- Paper Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds? DOI 10.1097/sla.0000000000004147↗
- Paper Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-der… DOI 10.1101/2021.08.26.457743↗
- Giuseppe Malleo · 1 shared paper, 2022 · strength 0.13
- Laura Maggino · 1 shared paper, 2022 · strength 0.13
- Claudio Bassi · 1 shared paper, 2022 · strength 0.13
- Salvatore Paiella · 1 shared paper, 2022 · strength 0.13
- Giovanni Marchegiani · 1 shared paper, 2022 · strength 0.13
- Roberto Salvia · 1 shared paper, 2022 · strength 0.13
- Willem Niesen · 1 shared paper, 2022 · strength 0.12
- Martin A. Schneider · 1 shared paper, 2022 · strength 0.12
- Markus K. Diener · 1 shared paper, 2022 · strength 0.12
- Christoph Springfeld · 1 shared paper, 2022 · strength 0.12
- Solange Le Blanc · 1 shared paper, 2021 · strength 0.10
- Sebastian Schuth · 1 shared paper, 2021 · strength 0.10
- Nathalia A. Giese · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.